Fidia S.p.A. (BIT:FDA)
Italy · Delayed Price · Currency is EUR | Market Cap | 165.20K -87.1% |
| Revenue (ttm) | 21.13M -28.9% |
| Net Income | -2.19M |
| EPS | -1.15 |
| Shares Out | 20.65M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 40,474,682 |
| Average Volume | 21,046,100 |
| Open | 0.0080 |
| Previous Close | 0.0080 |
| Day's Range | 0.0074 - 0.0094 |
| 52-Week Range | 0.0030 - 0.7400 |
| Beta | 0.42 |
| RSI | 44.44 |
| Earnings Date | May 22, 2026 |
About Fidia
Fidia S.p.A., together with its subsidiaries, designs, manufactures, and sells high speed milling systems, numerical controls, milling heads, and software systems. The company offers HMS, a device for measuring and compensating geometric error on continuous or indexed bi-rotary heads and roto-tilting tables; TMSC, a device to measure length and diameter of the tool, as well as to check the shape; pushbutton panels; XPower digital drives for axis and spindle movement; and I/O Line input/output modules. It also provides software solutions include... [Read more]
Financial Performance
In 2024, Fidia's revenue was 17.53 million, a decrease of -38.98% compared to the previous year's 28.74 million. Losses were -9.30 million, 611.4% more than in 2023.
Financial StatementsNews
20k medical shops shut in Mumbai, 200 kept open for emergencies amid strike
Mumbai saw 20,000 medical shops shut in an AIOCD strike against online medicine delivery; 200 pharmacies stayed open for emergencies as FDA ran a helpline.
Guardant Health (GH) Shares Rise Following FDA Approval of Guardant360 Liquid CDx
Guardant Health (GH) Shares Rise Following FDA Approval of Guardant360 Liquid CDx
My Top 3 Biotech Stocks for May 2026
As FDA activity accelerates and big pharma searches for its next generation of blockbuster drugs, select biotech companies are beginning to stand out from the crowd.
Why ImmunityBio Stock is Soaring Higher Today
ImmunityBio's stock is moving higher after the FDA announced it would review a possible label expansion for the company's core Anktiva drug.
ImmunityBio (IBRX) Gains 9% on FDA Acceptance of Anktiva Marketing Application
ImmunityBio (IBRX) Gains 9% on FDA Acceptance of Anktiva Marketing Application
Guardant Health (GH) Gains FDA Approval for New Liquid Biopsy Test
Guardant Health (GH) Gains FDA Approval for New Liquid Biopsy Test
Guardant Health: FDA Approves Guardant360 Liquid CDx
(RTTNews) - Guardant Health (GH) announced that the FDA has approved Guardant360 Liquid CDx, advancing blood-based comprehensive genomic testing by integrating genomic and epigenomic insights. Guardan...
Lupin bets big on India's GLP-1 market & respiratory drugs
Lupin's Global CFO Ramesh Swaminathan says the company is seeing promising early demand in India’s GLP-1 market and plans to expand into additional geographies, while building out its respiratory and ...
Achieve Life Sciences Unveils 52 Week Safety Data Of Cytisinicline Ahead Of FDA Decision
(RTTNews) - Achieve Life Sciences, Inc. (ACHV), a late-stage specialty pharmaceutical company, announced the presentation of long-term safety data from the ORCA-OL study evaluating its lead investigat...
ImmunityBio (IBRX) Secures FDA Review for Bladder Cancer Treatment
ImmunityBio (IBRX) Secures FDA Review for Bladder Cancer Treatment
IAS officer Tukaram Munde is Maha FDA chief: His 25th transfer in 21-year career
Maharashtra transfers: IAS officer Tukaram Mundhe appointed FDA Commissioner in his 25th transfer; Kanhuraj Bagate named MMRCL MD; Shridhar Dube shifted.
Medical shop strike on May 20, FDA releases emergency contacts
Nationwide one-day pharmacy strike may disrupt medicine supply; Maharashtra FDA sets up control room (9890293253) and Mumbai zone contacts for assistance.
The FDA Is Finally Considering a New Sunscreen Ingredient. Here's What to Know
Europeans have been using bemotrizinol for years. Why has the U.S. taken so long to adopt it?
FDA Grants Cullinan Orphan Drug Designation For CLN-049 In Treating Leukemia
(RTTNews) - Cullinan Therapeutics Inc. (CGEM), a clinical-stage biopharmaceutical company, on Tuesday announced that the U.S. Food and Drug Administration had granted CLN-049 an Orphan Drug designatio...
Lantern Pharma (LTRN) Receives FDA Support for Phase 2 Trial
Lantern Pharma (LTRN) Receives FDA Support for Phase 2 Trial
Sun Pharma Advanced Research partner receives FDA response on PDP-716 application
Sun Pharma Advanced Research Company (SPARC) has announced that its licensing partner, Ocuvex Therapeutics Inc., has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administratio...
Cullinan Therapeutics Gets FDA Orphan Drug Status For CLN-049 In Acute Myeloid Leukemia
(RTTNews) - Cullinan Therapeutics, Inc. (CGEM) on Tuesday said the U.S. Food and Drug Administration has granted Orphan Drug Designation to CLN-049 for the treatment of Acute Myeloid Leukemia.
Bayer (BAYRY) Receives FDA Priority Review for Asundexian in Stroke Prevention
Bayer (BAYRY) Receives FDA Priority Review for Asundexian in Stroke Prevention
Gossamer Bio Q1 Net Loss Expands; Eyes On The Pre-NDA Meeting With FDA For Seralutinib W In Mid-June
(RTTNews) - Gossamer Bio, Inc. (GOSS), a clinical-stage biopharmaceutical company, on Monday announced its financial results for the first quarter ended March 31, 2026, reflecting a wider net loss and...
FDA provides helpline numbers ahead of May 20 chemists’ strike
Nagpur: The Food and Drug Administration (FDA) announced emergency contact numbers and initiated measures to ensure uninterrupted availability of medi.
Hedge Fund Wagers $36 Million on Biotech Denali After First FDA Approval
This biotech develops therapies for neurodegenerative diseases, advancing a broad pipeline through strategic pharmaceutical partnerships.
What to Know About This Fund’s New $22 Million Xenon Pharmaceuticals Buy Ahead of an FDA Filing
Xenon Pharmaceuticals develops therapies for neurological disorders, with a pipeline targeting epilepsy and related conditions.
FDA's top drug regulator ousted amid agency upheaval
Upheaval among the top ranks of the Food and Drug Administration continued late Friday when Tracey Beth Høeg, the agency’s top drug regulator, was ousted. Høeg had served as acting director of the FDA...
AstraZeneca (AZN) Secures FDA Approval for Groundbreaking Treatment
AstraZeneca (AZN) Secures FDA Approval for Groundbreaking Treatment
VTRS Secures FDA Review for Non-Opioid Pain Treatment
VTRS Secures FDA Review for Non-Opioid Pain Treatment